Agomab to Participate in Upcoming Investor Conferences
Agomab Therapeutics (Nasdaq: AGMB), a clinical-stage biopharmaceutical company focused on fibro-inflammation, announced management participation in four investor conferences in September 2026, all in New York. The schedule includes Citi's 2026 Biopharma Back to School Conference on September 10, plus fireside chats at the Cantor Global Healthcare Conference (September 11, 8:00 AM ET), the H.C. Wainwright 28th Annual Global Investment Conference (September 15, 2:00 PM ET), and the Morgan Stanley 24th Annual Global Healthcare Conference (September 16, 9:15 AM ET).
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.